Overview

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Status:
Unknown status

Trial end date:
2019-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to confirm the safety and efficacy of Apatinib in Combination With Radiotherapy / Chemotherapy for Second-line and Above Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Henan Cancer Hospital

Collaborator:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

Apatinib